Tyrone S Beitaki

PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma

Matthew D. Dun, M. Cairns, D. Eisenstat, 2023, bioRxiv.

ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma

Matthew D. Dun, E. Pasquier, D. Eisenstat, 2023, Cancer research.

PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma

Matthew D. Dun, D. Eisenstat, F. Alvaro, 2024, The Journal of clinical investigation.